Appropriateness of colonoscopy in Europe (EPAGE II): Screening for colorectal cancer

Endoscopy

Volumn 41, Issue 3, 2009, Pages 200-208

  Arditi, C ^a   Peytremann Bridevaux, I ^a   Burnand, B ^a   Eckardt, Volker F ^b   Bytzer, Peter ^c   Agréus, Lars ^d   Dubois, R W ^e   Vader, J P ^a   Froehlich, F ^a,f   Pittet, V ^a   Schussele Filliettaz S ^a   Juillerat, P ^a   Gonvers, J J ^a,p   Beglinger, Christoph ^f   Delvaux, Michel ^g   Fairclough, Peter D ^h   Lacaine, François ⁱ   Le Moine, Olivier ^j   Lorenzo Zúñiga, Vicente ^k   Minoli, Giorgio ^l   Numans, Mattijs E ^m   Oertli, Daniel ⁿ   O'Malley, John ^l   Windsor, Alastair ^o   more..

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

^c Mental Health Services CPH   (Denmark)

^d KAROLINSKA INSTITUTE   (Sweden)

^e Cerner LifeSciences   (United States)

^f UNIVERSITY OF BASEL   (Switzerland)

^g UNIVERSITY HOSPITAL OF NANCY   (France)

^h BARTS HEALTH NHS TRUST   (United Kingdom)

ⁱ HÔPITAL TENON   (France)

^j ERASME HOSPITAL   (Belgium)

^k HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^l University Medical Center Utrecht ^*

^m UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

ⁿ UNIVERSITY HOSPITAL BASEL   (Switzerland)

^o UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^p POLICLINIQUE MÉDICALE UNIVERSITAIRE   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; ENDOSCOPIC POLYPECTOMY; EUROPE; FAMILY HISTORY; GASTROINTESTINAL ENDOSCOPY; HUMAN; OCCULT BLOOD TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECTUM ADENOMA; SIGMOIDOSCOPY; SYSTEMATIC REVIEW; COLORECTAL TUMOR; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW;

COLONOSCOPY; COLORECTAL NEOPLASMS; EUROPE; GUIDELINES AS TOPIC; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 67649393457     PISSN: 0013726X     EISSN: 14388812     Source Type: Journal    
DOI: 10.1055/s-0028-1119626     Document Type: Article

References (102)

1. Ferlay J, Autier P, Boniol M et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18: 581-592
2. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43-66
3. Fleshner P, Slater G, Aufses AH jr. Age and sex distribution of patients with colorectal cancer. Dis Colon Rectum 1989; 32: 107-111
4. Sant M, Capocaccia R, Verdecchia A et al. Comparisons of colon-cancer survival among European countries: The Eurocare Study. Int J Cancer 1995; 63: 43-48
5. Winawer SJ, Fletcher RH, Miller L et al. Colorectal cancer screening - clinical guidelines and rationale. Gastroenterology 1997; 112: 594-642
6. Burnand B, Bochud M, Froehlich F et al. 14. Appropriateness of colonoscopy: screening for colorectal cancer in asymptomatic individuals. Endoscopy 1999; 31: 673-683
7. Juillerat P, Peytremann-Bridevaux I, Vader JP et al. Appropriateness of colonoscopy in Europe (EPAGE II) Presentation of methodology, general results, and analysis of complications. Endoscopy 2009; 41: 240-246
8. Rex DK, Cutler CS, Lemmel GT et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997; 112: 24-28
9. Harris JK, Froehlich F, Wietlisbach V et al. Factors associated with the technical performance of colonoscopy: An EPAGE Study. Dig Liver Dis 2007; 39: 678-689
10. Pickhardt PJ, Choi JR, Hwang I et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 2003; 349: 2191-2200
11. van Gelder RE, Nio CY, Florie J et al. Computed tomographic colonography compared with colonoscopy in patients at increased risk for colorectal cancer. Gastroenterology 2004; 127: 41-48
12. Adler A, Roll S, Marowski B et al. Appropriateness of colonoscopy in the era of colorectal cancer screening: a prospective, multicenter study in a private-practice setting (Berlin Colonoscopy Project 1, BECOP 1). Dis Colon Rectum 2007; 50: 1628-1638
13. Byeon JS, Yang SK, Kim TI et al. Colorectal neoplasm in asymptomatic Asians: a prospective multinational multicenter colonoscopy survey. Gastrointest Endosc 2007; 65: 1015-1022
14. Eisele R, Vogelsang E, Kraft K et al. Screening for colorectal lesions with high-resolution video colonoscopes in a German male average-risk population at 40 to 59 years of age. Z Gastroenterol 2007; 45: 952-957
15. Gonvers JJ, Harris JK, Wietlisbach V et al. A European view of diagnostic yield and appropriateness of colonoscopy. Hepatogastroenterology 2007; 54: 729-735
16. Imperiale TF, Wagner DR, Lin CY et al. Results of screening colonoscopy among persons 40 to 49 years of age. N Engl J Med 2002; 346: 1781-1785
17. Lieberman DA, Weiss DG, Bond JH et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 2000; 343: 162-168
18. Morikawa T, Kato J, Yamaji Y et al. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 2005; 129: 422-428
19. Regula J, Rupinski M, Kraszewska E et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med 2006; 355: 1863-1872
20. Schoenfeld P, Cash B, Flood A et al. Colonoscopic screening of averagerisk women for colorectal neoplasia. N Engl J Med 2005; 352: 2061-2068
21. Strul H, Kariv R, Leshno M et al. The prevalence rate and anatomic location of colorectal adenoma and cancer detected by colonoscopy in average-risk individuals aged 40-80 years. Am J Gastroenterol 2006; 101: 255-262
22. Sung JJ, Chan FK, Leung WK et al. Screening for colorectal cancer in Chinese: comparison of fecal occult blood test, flexible sigmoidoscopy, and colonoscopy. Gastroenterology 2003; 124: 608-614
23. Thiis-Evensen E, Hoff GS, Sauar J et al. Flexible sigmoidoscopy or colonoscopy as a screening modality for colorectal adenomas in older age groups? Findings in a cohort of the normal population aged 63-72 years. Gut 1999; 45: 834-839
24. Brenner H, Arndt V, Sturmer T et al. Long-lasting reduction of risk of colorectal cancer following screening endoscopy. Br J Cancer 2001; 85: 972-976
25. Cotterchio M, Manno M, Klar N et al. Colorectal screening is associated with reduced colorectal cancer risk: a case-control study within the population-based Ontario Familial Colorectal Cancer Registry. Cancer Causes Control 2005; 16: 865-875
26. Singh H, Turner D, Xue L et al. Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. JAMA 2006; 295: 2366-2373
27. Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Int Med 1995; 123: 904-910
28. Muller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med 1995; 155: 1741-1748
29. Kronborg O, Jorgensen OD, Fenger C, Rasmussen M. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scand J Gastroenterol 2004; 39: 846-851
30. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. JNCI 1999; 91: 434-437
31. Scholefield JH, Moss S, Sufi F et al. Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial. Gut 2002; 50: 840-844
32. Davila RE, Rajan E, Baron TH et al. ASGE guideline: colorectal cancer screening and surveillance. Gastrointest Endosc 2006; 63: 546-557
33. Imperiale TF, Wagner DR, Lin CY et al. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 2000; 343: 169-174
34. Lieberman DA, Weiss DG. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 2001; 345: 555-560
35. Bertario L, Russo A, Sala P et al. Predictors of metachronous colorectal neoplasms in sporadic adenoma patients. Int J Cancer 2003; 105: 82-87
36. Citarda F, Tomaselli G, Capocaccia R et al. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut 2001; 48: 812-815
37. Jorgensen OD, Kronborg O, Fenger C, Rasmussen M. Influence of longterm colonoscopic surveillance on incidence of colorectal cancer and death from the disease in patients with precursors (adenomas). Acta Oncol (Stockholm, Sweden) 2007; 46: 355-360
38. Thiis-Evensen E, Hoff GS, Sauar J et al. Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand J Gastroenterol 1999; 34: 414-420
39. Winawer SJ, Zauber AG, Ho MN et al. Prevention of colorectal cancer by colonoscopic polypectomy (The National Polyp Study Workgroup). N Engl J Med 1993; 329: 1977-1981
40. Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA 2000; 284: 1954-1961
41. Sonnenberg A, Delco F. Cost-effectiveness of a single colonoscopy in screening for colorectal cancer. Arch Intern Med 2002; 162: 163-168
42. Vijan S, Hwang EW, Hofer TP, Hayward RA. Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. Am J Med 2001; 111: 593-601
43. Australian Cancer Network Colorectal Cancer Guidelines Revision Committee. Guidelines for the prevention, early detection and management of colorectal cancer. Sydney: The Cancer Council Australia and Australian Cancer Network, 2005
44. Coombs A, Jones-McLean E, Le Petit C et al. Technical report for the National Committee on Colorectal Cancer Screening; 2002. Available at: www.phac-aspc.gc.ca/publicat/ncccs-cndcc/ackn-eng.php
45. Kaiser Permanente Care Management Institute. Colorectal cancer screening clinical practice guideline. Oakland, California: Kaiser Permanente Care Management Institute, 2006
46. Levin B, Burt RW, Drelichman E et al. Colorectal cancer screening. National Comprehensive Cancer Network, 2007
47. McLeod RS with the Canadian Task Force on Preventive Health Care. Screening strategies for colorectal cancer. Systematic review and recommendations. Canadian Task Force on Preventive Health Care, 2001
48. Rex DK, Johnson DA, Lieberman DA et al. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. American College of Gastroenterology. Am J Gastroenterol 2000; 95: 868-877
49. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin 2006; 56: 11-25
50. US Preventive Services Task Force. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med 2002; 137: 129-131
51. Winawer S, Fletcher R, Rex D et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale - update based on new evidence. Gastroenterology 2003; 124: 544-560
52. Levin B, Lieberman DA, McFarland B et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008; 134: 1570-1595
53. Lieberman DA, Weiss DG, Harford WV et al. Five-year colon surveillance after screening colonoscopy. Gastroenterology 2007; 133: 1077-1085
54. Rex DK, Cummings OW, Helper DJ et al. 5-year incidence of adenomas after negative colonoscopy in asymptomatic average-risk persons. Gastroenterology 1996; 111: 1178-1181
55. Allison JE, Sakoda LC, Levin TR et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. JNCI 2007; 99: 1462-1470
56. Allison JE, Tekawa IS, Ransom LJ, Adrain AL. A comparison of fecal occult blood tests for colorectal cancer screening. N Engl J Med 1996; 334: 155-159
57. Greenberg PD, Bertario L, Gnauck R et al. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy. Am J Gastroenterol 2000; 95: 1331-1338
58. Brevinge H, Lindholm E, Buntzen S, Kewenter J. Screening for colorectal neoplasia with faecal occult blood testing compared with flexible sigmoidoscopy directly in a 55-56 years old population. Int J Colorect Dis 1997; 12: 291-295
59. Hardcastle JD, Chamberlain JO, Robinson MH et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-1477
60. Jorgensen OD, Kronborg O, Fenger C. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut 2002; 50: 29-32
61. Kewenter J, Brevinge H, Engaras B et al. Follow-up after screening for colorectal neoplasms with fecal occult blood testing in a controlled trial. Dis Colon Rectum 1994; 37: 115-119
62. Kronborg O, Fenger C, Olsen J et al. Randomised study of screening for colorectal cancer with faecal occult blood test. Lancet 1996; 348: 1467-1471
63. Mandel JS, Bond JH, Church TR et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993; 328: 1365-1371
64. Mandel JS, Church TR, Bond JH et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000; 343: 1603-1607
65. Hewitson P, Glasziou P, Irwig L et al. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev 2007; CD001216:
66. Lang CA, Ransohoff DF. Fecal occult blood screening for colorectal cancer. is mortality reduced by chance selection for screening colonoscopy? Jama 1994; 271: 1011-1013
67. Solomon MJ, McLeod RS. Periodic health examination, 1994 update: 2. Screening strategies for colorectal cancer. Canadian Task Force on the Periodic Health Examination. Can Med Assoc J 1994; 150: 1961-1970
68. Foutch PG, Mai H, Pardy K et al. Flexible sigmoidoscopy may be ineffective for secondary prevention of colorectal cancer in asymptomatic, average-risk men. Dig Dis Sci 1991; 36: 924-928
69. Lieberman DA, Smith FW. Screening for colon malignancy with colonoscopy. Am J Gastroenterol 1991; 86: 946-951
70. Anderson JC, Alpern Z, Messina CR et al. Predictors of proximal neoplasia in patients without distal adenomatous pathology. Am J Gastroenterol 2004; 99: 472-477
71. Hoff G, Sauar J, Vatn MH et al. Polypectomy of adenomas in the prevention of colorectal cancer: 10 years' follow-up of the Telemark Polyp Study I. A prospective, controlled population study. Scand J Gastroenterol 1996; 31: 1006-1010
72. Thiis-Evensen E, Hoff GS, Sauar J et al. The effect of attending a flexible sigmoidoscopic screening program on the prevalence of colorectal adenomas at 13-year follow-up. Am J Gastroenterol 2001; 96: 1901-1907
73. UK Flexible Simoidoscopy Screening Trial Investigators. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet 2002; 359: 1291-1300
74. Atkin WS, Edwards R, Wardle J et al. Design of a multicentre randomised trial to evaluate flexible sigmoidoscopy in colorectal cancer screening. J Med Screen 2001; 8: 137-144
75. Bretthauer M, Gondal G, Larsen K et al. Design, organization and management of a controlled population screening study for detection of colorectal neoplasia: attendance rates in the NORCCAP study (Norwegian Colorectal Cancer Prevention). Scand J Gastroenterol 2002; 37: 568-573
76. Gondal G, Grotmol T, Hofstad B et al. The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50-64 years. Scand J Gastroenterol 2003; 38: 635-642
77. Segnan N, Senore C, Andreoni B et al. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. JNCI 2005; 97: 347-357
78. Segnan N, Senore C, Andreoni B et al. Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoscopy" - SCORE. JNCI 2002; 94: 1763-1772
79. Segnan N, Senore C, Andreoni B et al. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology 2007; 132: 2304-2312
80. Weissfeld JL, Schoen RE, Pinsky PF et al. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial. JNCI 2005; 97: 989-997
81. Newcomb PA, Storer BE, Morimoto LM et al. Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. JNCI 2003; 95: 622-625
82. Slattery ML, Edwards SL, Ma KN, Friedman GD. Colon cancer screening, lifestyle, and risk of colon cancer. Cancer Causes Control 2000; 11: 555-563
83. Mulhall BP, Veerappan GR, Jackson JL. Meta-analysis: computed tomographic colonography. Ann Int Med 2005; 142: 635-650
84. Imperiale TF, Ransohoff DF, Itzkowitz SH et al. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004; 351: 2704-2714
85. Butterworth AS, Higgins JPT, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: ameta-analysis. Eur J Cancer 2006; 42: 216-227
86. Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol 2001; 96: 2992-3003
87. Cottet V, Pariente A, Nalet B et al. Colonoscopic screening of first-degree relatives of patients with large adenomas: increased risk of colorectal tumors. Gastroenterology 2007; 133: 1086-1092
88. Guillem JG, Forde KA, Treat MR et al. Colonoscopic screening for neoplasms in asymptomatic first- degree relatives of colon cancer patients. A controlled, prospective study. Dis Colon Rectum 1992; 35: 523-529
89. Rex DK. Colonoscopy: a reviewof its yield for cancers and adenomas by indication. Am J Gastroenterol 1995; 90: 353-365
90. Sauar J, Hausken T, Hoff G et al. Colonoscopic screening examination of relatives of patients with colorectal cancer. I. A comparison with an endoscopically screened normal population. Scand J Gastroenterol 1992; 27: 661-666
91. Dowling DJ, St John DJ, Macrae FA, Hopper JL. Yield from colonoscopic screening in people with a strong family history of common colorectal cancer. J Gastroenterol Hepatol 2000; 15: 939-944
92. Niv Y, Dickman R, Figer A et al. Case-control study of screening colonoscopy in relatives of patients with colorectal cancer. Am J Gastroenterol 2003; 98: 486-489
93. French National Agency for Accreditation and Evaluation in Healthcare. Clinical practice guidelines: indications for lower gastrointestinal endoscopy (excluding population screening). 2004. Available at: http://www.has-sante.fr/portail/upload/docs/application/pdf/Endoscopy- guidelines.pdf
94. New Zealand Guidelines Group. Surveillance and management of groups at increased risk of colorectal cancer. Wellington, New Zealand: New Zealand Guidelines Group (NZGG); 2004. Available at: www.nzgg.org.nz/guidelines/ 0048/040624-FINAL-Full-for-Web-Colorectal-Guideline1.pdf
95. Cairns S, Scholefield JH. Guidelines for colorectal cancer screening in high risk groups. Gut 2002; 51 Suppl 5: V1-V2
96. Scottish Intercollegiate Guidelines Network. Management of colorectal cancer. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN), 2003
97. Vasen HF, Mecklin JP, Watson P et al. Surveillance in hereditary nonpolyposis colorectal cancer: an international cooperative study of 165 families. The International Collaborative Group on HNPCC. Dis Colon Rectum 1993; 36: 1-4
98. Vasen HF, Moslein G, Alonso A et al. Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet 2007; 44: 353-362
99. Lynch HT, Smyrk T, Lynch J et al. Update on the differential diagnosis, surveillance and management of hereditary non-polyposis colorectal cancer. Eur J Cancer 1995; 31A : 1039-1046
100. Jarvinen HJ, Aarnio M, Mustonen H et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000; 118: 829-834
101. Jarvinen HJ, Mecklin JP, Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 1995; 108: 1405-1411
102. Heiskanen I, Luostarinen T, Jârvinen HJ. Impact of screening examinations on survival in familial adenomatous polyposis. Scand J Gastroenterol 2000; 35: 1284-1287